I agree there other problems the EA biosecurity community focuses on, but surely lab escapes are one of those problems, and part of the reason we need biosecurity measures? In any case, this disagreement seems beside the main point that I took Adam to be making, namely that the track record for defining appropriate units of risk for poorly understood, high attack surface domains is quite bad (as with BSL). This still seems true to me.
BSL isn’t the thing that defines “appropriate units of risk”, that’s pathogen risk-group levels, and I agree that those are are problem because they focus on pathogen lists rather than actual risks. I actually think BSL are good at what they do, and the problem is regulation and oversight, which is patchy, as well as transparency, of which there is far too little. But those are issues with oversight, not with the types of biosecurity measure that are available.
I agree there other problems the EA biosecurity community focuses on, but surely lab escapes are one of those problems, and part of the reason we need biosecurity measures? In any case, this disagreement seems beside the main point that I took Adam to be making, namely that the track record for defining appropriate units of risk for poorly understood, high attack surface domains is quite bad (as with BSL). This still seems true to me.
BSL isn’t the thing that defines “appropriate units of risk”, that’s pathogen risk-group levels, and I agree that those are are problem because they focus on pathogen lists rather than actual risks. I actually think BSL are good at what they do, and the problem is regulation and oversight, which is patchy, as well as transparency, of which there is far too little. But those are issues with oversight, not with the types of biosecurity measure that are available.